BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7361667)

  • 1. Myocardial infarction in the dog: effects of intravenous propranolol.
    Fox K; Welman E; Selwyn A
    Am J Cardiol; 1980 Apr; 45(4):769-74. PubMed ID: 7361667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of propranolol on myocardial perfusion and metabolism during acute regional ischaemia.
    Fox KM; Selwyn AP; Welman E
    Clin Cardiol; 1980; 3(1):47-50. PubMed ID: 7379376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs.
    Selwyn AP; Welman E; Fox K; Horlock P; Pratt T; Klein M
    Circ Res; 1979 Jan; 44(1):16-23. PubMed ID: 758229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental model for angina pectoris using krypton-81m. The dynamic balance between myocardial perfusion and metabolism.
    Fox KM; Selwyn AP; Welman E
    Eur J Cardiol; 1979 Aug; 10(2):151-62. PubMed ID: 477704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of propranolol on myocardial damage resulting from coronary artery occlusion followed by reperfusion.
    Miyazawa K; Fukuyama H; Komatsu E; Yamaguchi I
    Am Heart J; 1986 Mar; 111(3):519-24. PubMed ID: 3953361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
    Vik-Mo H; Maroko PR; Ribeiro LG
    J Am Coll Cardiol; 1984 Oct; 4(4):735-41. PubMed ID: 6481013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion.
    Radvany P; Maroko PR; Braunwald E
    Am J Cardiol; 1975 Jun; 35(6):795-800. PubMed ID: 1130288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propranolol and nitroglycerin plus methoxamine on transmural creatine kinase activity after acute coronary occlusion.
    Jesmok GJ; Gross GJ; Hardman HF
    Am J Cardiol; 1978 Nov; 42(5):769-73. PubMed ID: 101067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of disturbed myocardial perfusion in patients with coronary artery disease. Regional myocardial perfusion in angina pectoris.
    Selwyn AP; Forse G; Fox K; Jonathan A; Steiner R
    Circulation; 1981 Jul; 64(1):83-90. PubMed ID: 7237730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of propranolol on experimental periinfarction block and myocardial ischemia.
    Carp C
    Med Interne; 1977; 15(4):395-410. PubMed ID: 594624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
    KU DD; Lucchesi BR
    Circulation; 1978 Mar; 57(3):541-8. PubMed ID: 624163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs.
    Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M
    Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of intravenous propranolol in predicting left anterior descending blood flow during anterior myocardial infarction.
    Gold HK; Leinbach RC; Harper RW
    Am J Cardiol; 1984 Aug; 54(3):264-8. PubMed ID: 6465002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury.
    Muller JE; Maroko PR; Braunwald E
    Circulation; 1975 Jul; 52(1):16-27. PubMed ID: 1132119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
    Shell WE; Lavelle JF; Covell JW; Sobel BE
    J Clin Invest; 1973 Oct; 52(10):2579-90. PubMed ID: 4729051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nifedipine on creatine kinase release during myocardial ischemia in dogs.
    Welman E; Carroll BJ; Lawson JS; Selwyn AP; Fox KM
    Eur J Cardiol; 1978 Jul; 7(5-6):379-89. PubMed ID: 699937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion.
    Kjekshus JK; Mjos OD
    J Clin Invest; 1973 Jul; 52(7):1770-8. PubMed ID: 4718963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.